SapiensBio is a data-driven technology-based drug discovery company focusing on the discovery of novel drug candidates for the treatment of sever diseases where there is a clear unmet medical need. We are integrating machine learning technology with wet lab work to solve biological complexity and increase the efficiency of drug discovery from target identification to clinical candidate selection.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Korea - South Korea
Year Founded:
2018
Main Therapeutic Focus:
Multiple Therapeutics
Lead Product in Development:
SBC-101
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
One
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
